In a groundbreaking move, Nasdaq-listed Eyenovia Inc. (EYEN) has announced a $50 million investment into the cryptocurrency space, focusing on the HYPE token from the Hyperliquid blockchain. This strategic decision marks the company as one of the first U.S. public firms to build a dedicated crypto treasury reserve, highlighting the growing intersection of traditional finance and decentralized technologies.
The funds for this investment were secured through a private placement in public equity (PIPE) financing with institutional investors. Eyenovia plans to acquire over 1 million HYPE tokens, positioning itself as a significant player in the Hyperliquid ecosystem. This move is part of a broader treasury strategy to diversify assets and embrace innovative financial instruments.
Alongside this investment, Eyenovia is undergoing a rebranding to Hyperion DeFi, with its stock ticker changing from EYEN to HYPD around June 20, 2025. The company also appointed Hyunsu Jung as Chief Investment Officer and Board member to oversee its crypto initiatives, signaling a strong commitment to this new direction.
Despite this pivot, Eyenovia has assured stakeholders that it will continue its core operations in ophthalmic technology, particularly the development of the Optejet User Filled Device (UFD). The dual focus aims to balance innovation in healthcare with cutting-edge financial strategies.
The announcement has already made waves in the market, with Eyenovia’s stock soaring by over 136% following the news. This surge reflects investor confidence in the company’s bold approach to integrating cryptocurrency into its financial framework, potentially setting a precedent for other public companies.
As decentralized finance (DeFi) continues to gain traction, Eyenovia’s investment in HYPE tokens could pave the way for greater institutional adoption of blockchain technologies. Industry experts are watching closely to see if this $50 million gamble transforms into a genius move for the newly branded Hyperion DeFi.
Alfred Lee
